Found: 76
Select item for more details and to access through your institution.
Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma.
- Published in:
- International Journal of Hematology, 2015, v. 101, n. 1, p. 37, doi. 10.1007/s12185-014-1696-6
- By:
- Publication type:
- Article
Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agents.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 4, p. 441, doi. 10.1007/s12185-014-1539-5
- By:
- Publication type:
- Article
Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Constitutively activated Rho guanosine triphosphatases regulate the growth and morphology of hairy cell leukemia cells.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Constitutively Activated Rho Guanosine Triphosphatases Regulate the Growth and Morphology of Hairy Cell Leukemia Cells.
- Published in:
- International Journal of Hematology, 2003, v. 77, n. 3, p. 263, doi. 10.1007/BF02983784
- By:
- Publication type:
- Article
Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 4694, doi. 10.3390/ijms23094694
- By:
- Publication type:
- Article
Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-32426-6
- By:
- Publication type:
- Article
Venetoclax Combined with Azacytidine Can Be a First-line Treatment Option for Elderly Blastic Plasmacytoid Dendritic Cell Neoplasm.
- Published in:
- Internal Medicine, 2023, v. 62, n. 17, p. 2547, doi. 10.2169/internalmedicine.0318-22
- By:
- Publication type:
- Article
Prolonged gut microbial alterations in post‐transplant survivors of allogeneic haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. 725, doi. 10.1111/bjh.18574
- By:
- Publication type:
- Article
Identification of CXCL12‐abundant reticular cells in human adult bone marrow.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 659, doi. 10.1111/bjh.17396
- By:
- Publication type:
- Article
Pre‐ and post‐serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 3, p. 438, doi. 10.1111/bjh.16205
- By:
- Publication type:
- Article
A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 5, p. 745, doi. 10.1111/bjh.13900
- By:
- Publication type:
- Article
A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 475, doi. 10.1007/s00277-023-05428-7
- By:
- Publication type:
- Article
A multi-center retrospective analysis of patients with relapsed/refractory follicular lymphoma after third-line chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03711-8
- By:
- Publication type:
- Article
Roles of tyrosine residues 845, 892 and 922 in constitutive activation of murine FLT3 kinase domain mutant.
- Published in:
- Oncogene, 2005, v. 24, n. 55, p. 8144, doi. 10.1038/sj.onc.1208957
- By:
- Publication type:
- Article
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 555, doi. 10.1111/ejh.13586
- By:
- Publication type:
- Article
Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia.
- Published in:
- Stem Cells, 2021, v. 39, n. 6, p. 723, doi. 10.1002/stem.3348
- By:
- Publication type:
- Article
Monocyte or white blood cell counts and β<sub>2</sub> microglobulin predict the durable efficacy of daratumumab with lenalidomide.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221142487
- By:
- Publication type:
- Article
Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221104584
- By:
- Publication type:
- Article
Whole‐exome sequencing identified mutational profile of a case with T‐cell chronic lymphocytic leukemia.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 11, p. 2251, doi. 10.1002/ccr3.3149
- By:
- Publication type:
- Article
Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 2, p. 153, doi. 10.1007/s00228-015-1967-z
- By:
- Publication type:
- Article
Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma.
- Published in:
- Journal of Clinical & Experimental Hematopathology, 2023, v. 63, n. 2, p. 108, doi. 10.3960/jslrt.23005
- By:
- Publication type:
- Article
Phase I study of ibrutinib in Japanese patients with treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma.
- Published in:
- Journal of Clinical & Experimental Hematopathology, 2019, v. 59, n. 4, p. 179, doi. 10.3960/jslrt.19023
- By:
- Publication type:
- Article
Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 5, p. 621, doi. 10.1007/s12185-024-03834-9
- By:
- Publication type:
- Article
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021).
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 6, p. 707, doi. 10.1007/s12185-024-03754-8
- By:
- Publication type:
- Article
End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 6, p. 677, doi. 10.1007/s12185-024-03738-8
- By:
- Publication type:
- Article
Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 5, p. 609, doi. 10.1007/s12185-023-03653-4
- By:
- Publication type:
- Article
Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 2, p. 215, doi. 10.1007/s12185-022-03341-9
- By:
- Publication type:
- Article
ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Correction to: Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Nivolumab-induced systemic lymphadenopathy occurring during treatment of malignant melanoma: a case report.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 2, p. 302, doi. 10.1007/s12185-022-03312-0
- By:
- Publication type:
- Article
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 1, p. 33, doi. 10.1007/s12185-021-03216-5
- By:
- Publication type:
- Article
Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden.
- Published in:
- International Journal of Hematology, 2021, v. 114, n. 2, p. 217, doi. 10.1007/s12185-021-03151-5
- By:
- Publication type:
- Article
High numbers of programmed cell death-1-positive tumor infiltrating lymphocytes correlate with early onset of post-transplant lymphoproliferative disorder.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Flow cytometry analysis of peripheral Tregs in patients with multiple myeloma under lenalidomide maintenance.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 2, p. 219, doi. 10.1007/s12185-020-03013-6
- By:
- Publication type:
- Article
Subcutaneous delivery of daratumumab in Japanese patients with relapsed/refractory multiple myeloma.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 1, p. 112, doi. 10.1007/s12185-020-02985-9
- By:
- Publication type:
- Article
Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 4, p. 435, doi. 10.1007/s12185-020-02996-6
- By:
- Publication type:
- Article
Limbic encephalitis with antibodies to N-methyl-d-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 2, p. 254, doi. 10.1007/s12185-020-02859-0
- By:
- Publication type:
- Article
Daratumumab, lenalidomide, and dexamethasone in Japanese patients with transplant-ineligible newly diagnosed multiple myeloma: a phase 1b study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Noninvasive assessment of corneal alterations associated with monoclonal gammopathy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum.
- Published in:
- 2018
- By:
- Publication type:
- journal article